On the public citation graph

Alzheimer's disease; taking the edge off with cannabinoids?

https://doi.org/10.1038/sj.bjp.0707446
0 signed · 210 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.60.8.1119openalex-snapshot
Alzheimer Disease in the US Population
inferredcites →https://doi.org/10.1002/(sici)1099-1166(199709)12:9<913::aid-gps663>3.0.co;2-dopenalex-snapshot
Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease
inferredcites →https://doi.org/10.1002/glia.10177openalex-snapshot
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
inferredcites →https://doi.org/10.1002/syn.20050openalex-snapshot
Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study
inferredcites →https://doi.org/10.1007/3-540-26573-2_1openalex-snapshot
Pharmacological Actions of Cannabinoids
inferredcites →https://doi.org/10.1007/3-540-26573-2_15openalex-snapshot
Cannabinoid Function in Learning, Memory and Plasticity
inferredcites →https://doi.org/10.1007/s00018-006-6037-3openalex-snapshot
Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels
inferredcites →https://doi.org/10.1007/s00109-005-0025-1openalex-snapshot
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
inferredcites →https://doi.org/10.1007/s00213-006-0343-1openalex-snapshot
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
inferredcites →https://doi.org/10.1007/s00415-005-5007-2openalex-snapshot
Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis
inferredcites →https://doi.org/10.1016/0304-3940(93)90555-yopenalex-snapshot
The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain
inferredcites →https://doi.org/10.1016/0306-4522(94)90511-8openalex-snapshot
Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains
inferredcites →https://doi.org/10.1016/j.bcp.2006.08.018openalex-snapshot
R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB2 receptor
inferredcites →https://doi.org/10.1016/j.brainres.2006.11.063openalex-snapshot
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
inferredcites →https://doi.org/10.1016/j.ceca.2005.06.021openalex-snapshot
Calcium dysregulation in Alzheimer's disease: Recent advances gained from genetically modified animals
inferredcites →https://doi.org/10.1016/j.ejphar.2003.08.025openalex-snapshot
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task
inferredcites →https://doi.org/10.1016/j.ejphar.2003.08.026openalex-snapshot
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
inferredcites →https://doi.org/10.1016/j.ejphar.2006.11.006openalex-snapshot
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
inferredcites →https://doi.org/10.1016/j.jneuroim.2006.11.017openalex-snapshot
Inflammatory processes in Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.jns.2005.03.002openalex-snapshot
Cannabinoids and neuroprotection in CNS inflammatory disease
inferredcites →https://doi.org/10.1016/j.lfs.2004.03.026openalex-snapshot
Role of the endocannabinoid system in Alzheimer's disease: New perspectives
inferredcites →https://doi.org/10.1016/j.mcn.2006.12.005openalex-snapshot
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
inferredcites →https://doi.org/10.1016/j.nbd.2004.11.009openalex-snapshot
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
inferredcites →https://doi.org/10.1016/j.neulet.2005.11.038openalex-snapshot
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
inferredcites →https://doi.org/10.1016/j.neulet.2006.01.047openalex-snapshot
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
inferredcites →https://doi.org/10.1016/j.neuron.2006.08.003openalex-snapshot
Not Too Excited? Thank Your Endocannabinoids
inferredcites →https://doi.org/10.1016/j.neuropharm.2005.01.005openalex-snapshot
Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores
inferredcites →https://doi.org/10.1016/j.neuroscience.2004.05.040openalex-snapshot
Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress
inferredcites →https://doi.org/10.1016/j.neuroscience.2006.01.024openalex-snapshot
The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
inferredcites →https://doi.org/10.1016/j.phrs.2004.05.005openalex-snapshot
Dementia of Alzheimer’s disease and other neurodegenerative disorders—memantine, a new hope
inferredcites →https://doi.org/10.1016/j.tips.2006.11.001openalex-snapshot
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
inferredcites →https://doi.org/10.1016/s0006-8993(97)01195-5openalex-snapshot
The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons
inferredcites →https://doi.org/10.1016/s0014-2999(03)01734-5openalex-snapshot
Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes
inferredcites →https://doi.org/10.1016/s0197-4580(02)00060-xopenalex-snapshot
β-Amyloid(1–40)-induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase
inferredcites →https://doi.org/10.1016/s0304-3940(01)02065-1openalex-snapshot
Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
inferredcites →https://doi.org/10.1016/s0304-3940(02)00936-9openalex-snapshot
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide
inferredcites →https://doi.org/10.1016/s0304-3940(99)00545-5openalex-snapshot
Evidence for activation of microglia in patients with psychiatric illnesses
inferredcites →https://doi.org/10.1016/s0896-6273(00)80108-7openalex-snapshot
Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
inferredcites →https://doi.org/10.1016/s0896-6273(01)00402-0openalex-snapshot
Stores Not Just for Storage
inferredcites →https://doi.org/10.1016/s0898-6568(03)00036-6openalex-snapshot
Activation of phosphoinositide 3-kinase/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction
inferredcites →https://doi.org/10.1021/mp060066mopenalex-snapshot
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology
inferredcites →https://doi.org/10.1038/372686a0openalex-snapshot
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
inferredcites →https://doi.org/10.1038/42015openalex-snapshot
A second endogenous cannabinoid that modulates long-term potentiation
inferredcites →https://doi.org/10.1038/71548openalex-snapshot
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
inferredcites →https://doi.org/10.1038/71555openalex-snapshot
Glutamate excitotoxicity in a model of multiple sclerosis
inferredcites →https://doi.org/10.1038/nature01640openalex-snapshot
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
inferredcites →https://doi.org/10.1038/nm1474openalex-snapshot
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
inferredcites →https://doi.org/10.1038/nrn1247openalex-snapshot
The molecular logic of endocannabinoid signalling
inferredcites →https://doi.org/10.1038/nrn960openalex-snapshot
Calcium dyshomeostasis and intracellular signalling in alzheimer's disease
inferredcites →https://doi.org/10.1038/sj.bjp.0703599openalex-snapshot
Cannabinoid receptor‐mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes
inferredcites →https://doi.org/10.1038/sj.bjp.0707003openalex-snapshot
Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
inferredcites →https://doi.org/10.1038/sj.jcbfm.9600047openalex-snapshot
CB 1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition
inferredcites →https://doi.org/10.1046/j.1471-4159.2001.00006.xopenalex-snapshot
Accumulation of the anandamide precursor and other N‐acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death
inferredcites →https://doi.org/10.1073/pnas.2634794100openalex-snapshot
Increased hippocampal neurogenesis in Alzheimer's disease
inferredcites →https://doi.org/10.1073/pnas.89.9.3825openalex-snapshot
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
inferredcites →https://doi.org/10.1073/pnas.90.22.10573openalex-snapshot
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.
inferredcites →https://doi.org/10.1073/pnas.95.14.8268openalex-snapshot
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
inferredcites →https://doi.org/10.1074/jbc.275.7.4713openalex-snapshot
Enhancement of 45Ca2+ Influx and Voltage-dependent Ca2+ Channel Activity by β-Amyloid-(1–40) in Rat Cortical Synaptosomes and Cultured Cortical Neurons
inferredcites →https://doi.org/10.1074/jbc.m002226200openalex-snapshot
Lipopolysaccharide Inhibits Long Term Potentiation in the Rat Dentate Gyrus by Activating Caspase-1
inferredcites →https://doi.org/10.1083/jcb.200210164openalex-snapshot
The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response
inferredcites →https://doi.org/10.1096/fj.06-6164fjeopenalex-snapshot
Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation
inferredcites →https://doi.org/10.1097/00001756-199312000-00013openalex-snapshot
HU-211, a nonpsychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture
inferredcites →https://doi.org/10.1111/j.1440-1681.2007.04610.xopenalex-snapshot
REGULATORS OF ADULT NEUROGENESIS IN THE HEALTHY AND DISEASED BRAIN
inferredcites →https://doi.org/10.1111/j.1460-9568.2004.03285.xopenalex-snapshot
Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity
inferredcites →https://doi.org/10.1111/j.1471-4159.2003.02327.xopenalex-snapshot
Neuroprotective effect of cannabidiol, a non‐psychoactive component fromCannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells
inferredcites →https://doi.org/10.1111/j.1471-4159.2006.04426.xopenalex-snapshot
Aβ Oligomers – a decade of discovery
inferredcites →https://doi.org/10.1124/jpet.106.107698openalex-snapshot
Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis
inferredcites →https://doi.org/10.1124/mol.54.3.459openalex-snapshot
Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity
inferredcites →https://doi.org/10.1126/science.1088208openalex-snapshot
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
inferredcites →https://doi.org/10.1126/science.1115740openalex-snapshot
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
inferredcites →https://doi.org/10.1152/jn.1997.78.1.43openalex-snapshot
Cannabinoids Inhibit N- and P/Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons
inferredcites →https://doi.org/10.1172/jci25509openalex-snapshot
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
inferredcites →https://doi.org/10.1177/1073858406296407openalex-snapshot
The Endocannabinoid System and Neurogenesis in Health and Disease
inferredcites →https://doi.org/10.1186/1742-2094-2-29openalex-snapshot
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
inferredcites →https://doi.org/10.1186/1742-2094-3-30openalex-snapshot
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.
inferredcites →https://doi.org/10.1212/wnl.45.1.51openalex-snapshot
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
inferredcites →https://doi.org/10.1358/dot.2006.42.8.1021517openalex-snapshot
Combined cannabinoid therapy via an oromucosal spray
inferredcites →https://doi.org/10.1385/jmn:15:2:99openalex-snapshot
Dietary Restriction Increases the Number of Newly Generated Neural Cells, and Induces BDNF Expression, in the Dentate Gyrus of Rats
inferredcites →https://doi.org/10.1517/14656566.8.2.203openalex-snapshot
Memantine in the treatment of mild-to-moderate Alzheimer’s disease
inferredcites →https://doi.org/10.1523/jneurosci.11-02-00563.1991openalex-snapshot
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
inferredcites →https://doi.org/10.1523/jneurosci.18-09-03213.1998openalex-snapshot
Stable Complexes Involving Acetylcholinesterase and Amyloid-β Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer’s Fibrils
inferredcites →https://doi.org/10.1523/jneurosci.23-16-06470.2003openalex-snapshot
Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia
inferredcites →https://doi.org/10.1523/jneurosci.23-35-11136.2003openalex-snapshot
Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains
inferredcites →https://doi.org/10.1523/jneurosci.4540-04.2005openalex-snapshot
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
inferredcites →https://doi.org/10.1523/jneurosci.4814-06.2007openalex-snapshot
Cannabinoid CB1and CB2Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis
inferredcites →https://doi.org/10.2174/156720506779025279openalex-snapshot
The Role of Tau Phosphorylation in the Pathogenesis of Alzheimers Disease
inferredcites →https://doi.org/10.2174/1568007033482670openalex-snapshot
Cannabinoids and Memory; Animal Studies

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3063288openalex-extracted
Helping Settle the Marijuana and Alcohol Debate: Evidence from Scanner Data
inferred← citeshttps://doi.org/10.1002/14651858.cd007204openalex-snapshot
Cannabinoids for the treatment of dementia
inferred← citeshttps://doi.org/10.1002/14651858.cd007204.pub2openalex-snapshot
Cannabinoids for the treatment of dementia
inferred← citeshttps://doi.org/10.1002/14651858.cd012820openalex-snapshot
Cannabinoids for the treatment of dementia
inferred← citeshttps://doi.org/10.1002/14651858.cd012820.pub2openalex-snapshot
Cannabinoids for the treatment of dementia
inferred← citeshttps://doi.org/10.1002/9780470572702.ch34openalex-snapshot
Current and Future Therapies for Alzheimer Disease
inferred← citeshttps://doi.org/10.1002/cmdc.201500041openalex-snapshot
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds
inferred← citeshttps://doi.org/10.1002/glia.23694openalex-snapshot
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
inferred← citeshttps://doi.org/10.1002/sae2.70055openalex-snapshot
Evaluating Ecosystem and Agronomic Services Provided by Companion Cropping in Hemp ( Cannabis sativa L.)
inferred← citeshttps://doi.org/10.1002/wmts.64openalex-snapshot
Cannabinoid receptors and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1007/978-1-4939-1071-7_23openalex-snapshot
Cannabinoids
inferred← citeshttps://doi.org/10.1007/978-3-319-73078-3_30openalex-snapshot
Special Management Problems
inferred← citeshttps://doi.org/10.1007/s10865-015-9625-6openalex-snapshot
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
inferred← citeshttps://doi.org/10.1007/s11011-018-0338-8openalex-snapshot
Trigonelline protects hippocampus against intracerebral Aβ(1–40) as a model of Alzheimer’s disease in the rat: insights into underlying mechanisms
inferred← citeshttps://doi.org/10.1007/s11055-026-01967-4openalex-snapshot
Mechanisms of Cognitive Aging: Health and Pathology
inferred← citeshttps://doi.org/10.1007/s12017-014-8314-xopenalex-snapshot
Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier
inferred← citeshttps://doi.org/10.1007/s12035-014-8957-5openalex-snapshot
From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists
inferred← citeshttps://doi.org/10.1007/s12272-010-1014-7openalex-snapshot
Phenolic compounds from Pueraria lobata protect PC12 cells against Aβ-induced toxicity
inferred← citeshttps://doi.org/10.1007/s13167-020-00203-4openalex-snapshot
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
inferred← citeshttps://doi.org/10.1016/b978-0-12-800756-3.00100-9openalex-snapshot
Synthetic Cannabinoids in Dementia
inferred← citeshttps://doi.org/10.1016/b978-0-12-802810-0.00006-4openalex-snapshot
Receptor Targets in Alzheimer’s Disease Drug Discovery
inferred← citeshttps://doi.org/10.1016/j.arr.2020.101041openalex-snapshot
The implications of late-life cannabis use on brain health: A mapping review and implications for future research
inferred← citeshttps://doi.org/10.1016/j.bbi.2017.08.015openalex-snapshot
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
inferred← citeshttps://doi.org/10.1016/j.bbr.2015.01.051openalex-snapshot
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
inferred← citeshttps://doi.org/10.1016/j.biopha.2008.02.004openalex-snapshot
Inflammation and aging: Can endocannabinoids help?
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111639openalex-snapshot
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2021.11.009openalex-snapshot
Parkinson’s disease related alterations in cannabinoid transmission
inferred← citeshttps://doi.org/10.1016/j.cbi.2011.10.001openalex-snapshot
Organic solvent metabolite, 1,2-diacetylbenzene, impairs neural progenitor cells and hippocampal neurogenesis
inferred← citeshttps://doi.org/10.1016/j.cell.2013.10.042openalex-snapshot
Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling
inferred← citeshttps://doi.org/10.1016/j.ejmech.2013.11.026openalex-snapshot
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.expneurol.2010.03.024openalex-snapshot
The endocannabinoid system and amyloid-related diseases
inferred← citeshttps://doi.org/10.1016/j.indcrop.2018.01.060openalex-snapshot
Variation in the compositions of cannabinoid and terpenoids in Cannabis sativa derived from inflorescence position along the stem and extraction methods
inferred← citeshttps://doi.org/10.1016/j.jddst.2017.04.023openalex-snapshot
Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.jhealeco.2015.03.007openalex-snapshot
The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances
inferred← citeshttps://doi.org/10.1016/j.jmgm.2021.107889openalex-snapshot
Destabilization of the Alzheimer’s amyloid-β protofibrils by THC: A molecular dynamics simulation study
inferred← citeshttps://doi.org/10.1016/j.lfs.2015.01.012openalex-snapshot
N-stearoyltyrosine protects primary cortical neurons against Aβ(1–40)-induced injury through inhibiting endocannabinoid degradation
inferred← citeshttps://doi.org/10.1016/j.mcn.2013.06.004openalex-snapshot
Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
inferred← citeshttps://doi.org/10.1016/j.neuint.2010.10.010openalex-snapshot
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
inferred← citeshttps://doi.org/10.1016/j.neuint.2011.10.019openalex-snapshot
CB1 receptor activation inhibits neuronal and astrocytic intermediary metabolism in the rat hippocampus
inferred← citeshttps://doi.org/10.1016/j.neuint.2016.09.005openalex-snapshot
G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2012.05.013openalex-snapshot
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2012.09.080openalex-snapshot
Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia
inferred← citeshttps://doi.org/10.1016/j.pbb.2014.07.006openalex-snapshot
Pretreatment with antiasthmatic drug ibudilast ameliorates Aβ1–42-induced memory impairment and neurotoxicity in mice
inferred← citeshttps://doi.org/10.1016/j.phrs.2018.02.009openalex-snapshot
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer’s disease-like mice overexpressing the human mutant amyloid precursor protein
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2024.170901openalex-snapshot
Evaluation of the effect of cannabidiol on the THLE-2 liver cell line exposed to lead
inferred← citeshttps://doi.org/10.1016/j.tox.2009.03.013openalex-snapshot
Neurotoxic effect of 2,5-hexanedione on neural progenitor cells and hippocampal neurogenesis
inferred← citeshttps://doi.org/10.1016/s0515-3700(09)70463-xopenalex-snapshot
Cannabis et cannabinoïdes en médecine
inferred← citeshttps://doi.org/10.1017/s1355617714000691openalex-snapshot
Association Between Interleukin-6 and Neurocognitive Performance as a Function of Self-Reported Lifetime Marijuana Use in a Community Based Sample of African American Adults
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.5b00949openalex-snapshot
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
inferred← citeshttps://doi.org/10.1038/npjamd.2016.12openalex-snapshot
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
inferred← citeshttps://doi.org/10.1038/s41531-024-00827-7openalex-snapshot
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
inferred← citeshttps://doi.org/10.1038/sj.bjp.0707483openalex-snapshot
Cannabinoids and their actions
inferred← citeshttps://doi.org/10.1039/d3fo05739aopenalex-snapshot
The role of tetrahydrocurcumin in disease prevention and treatment
inferred← citeshttps://doi.org/10.1042/bst20130140openalex-snapshot
Endocannabinoid signalling in Alzheimer's disease
inferred← citeshttps://doi.org/10.1074/jbc.m110.162040openalex-snapshot
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons
inferred← citeshttps://doi.org/10.1074/jbc.m112.350678openalex-snapshot
The Endocannabinoid, Anandamide, Augments Notch-1 Signaling in Cultured Cortical Neurons Exposed to Amyloid-β and in the Cortex of Aged Rats
inferred← citeshttps://doi.org/10.1080/02699052.2019.1679885openalex-snapshot
Cannabis, alcohol and cigarette use during the acute post-concussion period
inferred← citeshttps://doi.org/10.1080/10408398.2018.1552244openalex-snapshot
Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
inferred← citeshttps://doi.org/10.1097/fbp.0000000000000247openalex-snapshot
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease
inferred← citeshttps://doi.org/10.1101/2023.06.09.23291208openalex-snapshot
From Answers to Insights: Unveiling the Strengths and Limitations of ChatGPT and Biomedical Knowledge Graphs
inferred← citeshttps://doi.org/10.1101/2023.11.11.566677openalex-snapshot
Exploring the Therapeutic Potential of Cannabis Constituents in Parkinson’s Disease: Insights from Molecular Docking Studies
inferred← citeshttps://doi.org/10.1108/dat-06-2019-0021openalex-snapshot
Do medical cannabis growers attempt to produce cannabis with different cannabinoid concentrations than recreational growers?
inferred← citeshttps://doi.org/10.1111/caje.12437openalex-snapshot
Marijuana and alcohol: Evidence using border analysis and retail sales data
inferred← citeshttps://doi.org/10.1111/eci.12141openalex-snapshot
Tropisetron attenuates amyloid‐beta‐induced inflammatory and apoptotic responses in rats
inferred← citeshttps://doi.org/10.1111/fima.70037openalex-snapshot
Do Firms Get High? The Impact of Medical Marijuana Legalization on Firm Performance and Corporate Innovation
inferred← citeshttps://doi.org/10.1111/head.13345openalex-snapshot
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
inferred← citeshttps://doi.org/10.1111/j.1471-4159.2008.05278.xopenalex-snapshot
A role for p53 in the regulation of lysosomal permeability by Δ9‐tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2008.00088.xopenalex-snapshot
The endocannabinoid system as a target for the treatment of motor dysfunction
inferred← citeshttps://doi.org/10.1111/j.1755-5949.2010.00195.xopenalex-snapshot
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration
inferred← citeshttps://doi.org/10.1111/j.1755-5949.2010.00202.xopenalex-snapshot
Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?
inferred← citeshttps://doi.org/10.1155/2014/705451openalex-snapshot
Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation
inferred← citeshttps://doi.org/10.1155/2016/9815092openalex-snapshot
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
inferred← citeshttps://doi.org/10.1155/2017/1020357openalex-snapshot
Mitochondrial Ferritin Deletion Exacerbates β‐Amyloid‐Induced Neurotoxicity in Mice
inferred← citeshttps://doi.org/10.1159/000362689openalex-snapshot
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway
inferred← citeshttps://doi.org/10.1186/1742-2094-9-8openalex-snapshot
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
inferred← citeshttps://doi.org/10.1186/s12868-018-0406-3openalex-snapshot
RETRACTED ARTICLE: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1186/s13256-022-03457-wopenalex-snapshot
Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report
inferred← citeshttps://doi.org/10.1201/9781315367583-12openalex-snapshot
The Ecology of Wild Cannabis sativa
inferred← citeshttps://doi.org/10.1201/9781315367583-20openalex-snapshot
Cannabis Chemistry: Cannabinoids in Cannabis, Humans, and Other Species
inferred← citeshttps://doi.org/10.1248/bpb.b16-00997openalex-snapshot
2,4-Bis(1,1-dimethylethyl)phenol from Cinnamomum loureirii Improves Cognitive Deficit, Cholinergic Dysfunction, and Oxidative Damage in TMT-Treated Mice
inferred← citeshttps://doi.org/10.13040/ijpsr.0975-8232.1(9).52-57openalex-snapshot
inferred← citeshttps://doi.org/10.1371/journal.pone.0039186openalex-snapshot
Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease
inferred← citeshttps://doi.org/10.1387/ekaia.15800openalex-snapshot
Kannabisa: ageriko altxor ezkutua
inferred← citeshttps://doi.org/10.1517/14656566.2011.520702openalex-snapshot
Current perspectives on pharmacotherapy of Alzheimer's disease
inferred← citeshttps://doi.org/10.1517/14728222.2011.557363openalex-snapshot
Neurobiological aspects of Alzheimer's disease
inferred← citeshttps://doi.org/10.1517/14728222.2012.671812openalex-snapshot
The therapeutic potential of the endocannabinoid system for Alzheimer's disease
inferred← citeshttps://doi.org/10.15407/ubj91.05.016openalex-snapshot
Agonists of CB1 and NMDA receptors decrease the toxic effect of organophosphorus compound paraoxon on PC12 cells
inferred← citeshttps://doi.org/10.20944/preprints202304.0224.v1openalex-snapshot
(Endo)Cannabinoids and Cognitive Functions in Animals: Healthy and Pathological Brain
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4128466/v1openalex-snapshot
Evaluation of the protective effect of cannabidiol against cadmium-induced toxicity in 2D and 3D model THLE-2 liver cell line
inferred← citeshttps://doi.org/10.2174/138161208785740027openalex-snapshot
The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses
inferred← citeshttps://doi.org/10.2174/138955709788167628openalex-snapshot
Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
inferred← citeshttps://doi.org/10.2174/1570159x113116660047openalex-snapshot
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.2174/1570159x20666220327221830openalex-snapshot
Class A and C GPCR Dimers in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.2217/17460875.3.4.435openalex-snapshot
The ins and outs of endocannabinoid signaling in healthy and diseased brain
inferred← citeshttps://doi.org/10.2217/rme-2016-0032openalex-snapshot
Effect of Mesenchymal Stem Cells and Galantamine Nanoparticles in Rat Model of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.30598/belobelovol5issue2page1-20openalex-snapshot
Kebijakan Formulasi Undang-undang Narkotika Dalam Legalisasi Penggunaan Ganja Sebagai Bahan Pengobatan di Indonesia
inferred← citeshttps://doi.org/10.3109/13880209.2014.974062openalex-snapshot
Protective effect of centipedegrass against Aβoligomerization and Aβ-mediated cell death in PC12 cells
inferred← citeshttps://doi.org/10.3233/jad-130137openalex-snapshot
CB 2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
inferred← citeshttps://doi.org/10.3233/jad-140093openalex-snapshot
The Potential Therapeutic Effects of THC on Alzheimer's Disease
inferred← citeshttps://doi.org/10.3233/jad-140492openalex-snapshot
Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
inferred← citeshttps://doi.org/10.3233/jad-141014openalex-snapshot
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
inferred← citeshttps://doi.org/10.3233/jad-141635openalex-snapshot
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
inferred← citeshttps://doi.org/10.3233/jad-160533openalex-snapshot
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
inferred← citeshttps://doi.org/10.3233/jad-2012-111862openalex-snapshot
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
inferred← citeshttps://doi.org/10.3386/w20085openalex-snapshot
The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use
inferred← citeshttps://doi.org/10.3389/fncel.2016.00294openalex-snapshot
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
inferred← citeshttps://doi.org/10.3389/fphar.2016.00261openalex-snapshot
Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease
inferred← citeshttps://doi.org/10.3390/biomedicines10102492openalex-snapshot
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
inferred← citeshttps://doi.org/10.3390/cimb46050266openalex-snapshot
Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/ijms26157638openalex-snapshot
Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker
inferred← citeshttps://doi.org/10.3390/ph3082689openalex-snapshot
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
inferred← citeshttps://doi.org/10.3390/plants12030510openalex-snapshot
Investigation of Cannabis sativa Phytochemicals as Anti-Alzheimer’s Agents: An In Silico Study
inferred← citeshttps://doi.org/10.4088/pcc.14l01695openalex-snapshot
Nabilone for the Treatment of Dementia-Associated Sexual Disinhibition
inferred← citeshttps://doi.org/10.4236/ajmb.2023.132008openalex-snapshot
Cannabidiol-Mediated Sequestration of Alzheimer’s Amyloid-β Peptides in ADDL Oligomers
inferred← citeshttps://doi.org/10.4321/s2340-98942015000200002openalex-snapshot
Efecto neuroprotector de los cannabinoides en las enfermedades neurodegenerativas
inferred← citeshttps://doi.org/10.51486/jbo.v4i2.80openalex-snapshot
Legalization of Marijuana Use for Medical in Indonesia in Relation to Law Number 35 of 2009 concerning Narcotics
inferred← citeshttps://doi.org/10.54033/cadpedv22n9-161openalex-snapshot
Derivados da Canabbis no tratamento dos sintomas de portadores de Doença de Alzheimer – revisão de escopo
inferred← citeshttps://doi.org/10.5772/48558openalex-snapshot
Traditional and Modern Medicine Harmonizing the Two Approaches in the Treatment of Neurodegeneration (Alzheimer’s Disease – AD)
inferred← citeshttps://doi.org/10.5772/54783openalex-snapshot
Potential Therapeutic Strategies to Prevent the Progression of Alzheimer to Disease States
inferred← citeshttps://doi.org/10.5937/mckg49-9796openalex-snapshot
Use of cannabis in medicine and pharmacy
inferred← citeshttps://doi.org/10.7150/jca.28246openalex-snapshot
New Prospect for Cancer Cachexia: Medical Cannabinoid
inferred← citeshttps://doi.org/10.7439/ijpr.v5i7.2274openalex-snapshot
Novel therapies for treatment of Alzheimers Disease
inferred← citeshttps://doi.org/10.7727/wimj.2010.058openalex-snapshot
From Cannabis to the Endocannabinoid System: Refocussing Attention on Potential Clinical Benefits
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.